GFACX
Price
$70.96
Change
+$0.29 (+0.41%)
Updated
Jul 16 closing price
Net Assets
323.95B
RRGSX
Price
$101.22
Change
+$0.23 (+0.23%)
Updated
Jul 16 closing price
Net Assets
50.19B
Interact to see
Advertisement

GFACX vs RRGSX

Header iconGFACX vs RRGSX Comparison
Open Charts GFACX vs RRGSXBanner chart's image
American Funds Growth Fund of Amer C
Price$70.96
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets323.95B
T. Rowe Price Growth Stock R
Price$101.22
Change+$0.23 (+0.23%)
VolumeN/A
Net Assets50.19B
GFACX vs RRGSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. RRGSX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and RRGSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 324B vs. RRGSX (50.2B). GFACX (0.00) and RRGSX (0.00) have matching dividends . GFACX was incepted earlier than RRGSX: GFACX (24 years) vs RRGSX (23 years). GFACX (1.36) is less costly to investors than RRGSX (1.16). RRGSX is a more actively managed with annual turnover of: 38.20 vs. GFACX (25.00). GFACX has a lower initial minimum investment than RRGSX: GFACX (250) vs RRGSX (2500). GFACX annual gain was more profitable for investors over the last year : 7.11 vs. RRGSX (3.37). GFACX return over 5 years is better than : 35.91 vs. RRGSX (29.47).
GFACXRRGSXGFACX / RRGSX
Total Expense Ratio1.361.16117%
Annual Report Gross Expense Ratio1.361.16117%
Fund Existence24 years23 years-
Gain YTD11.2926.149184%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets324B50.2B645%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.113.37211%
Returns for 3 years52.0156.4392%
Returns for 5 years35.9129.47122%
Returns for 10 years63.3178.6880%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IKT1.860.06
+3.33%
Inhibikase Therapeutics
MKC71.380.63
+0.89%
McCormick & Company
VTS22.940.06
+0.26%
Vitesse Energy
ADN1.95N/A
N/A
Advent Technologies Holdings Inc.
BTE1.84-0.04
-2.13%
Baytex Energy Corp